Similar articles

• Some aspects of cell-mediated hypersensitivity in patients with melanoma.

  Moszkowska G, Jassem J, Kondrat W, Kopacz A, Goszczyńska E. Moszkowska G, et al. Arch Immunol Ther Exp (Warsz). 1980;28(4):655-60. Arch Immunol Ther Exp (Warsz). 1980. PMID: 6970028
• ["Transfer factor" in ophthalmology (author's transl)].

  Rocha H. Rocha H. Klin Monbl Augenheilkd. 1977 Jul;171(1):63-70. Klin Monbl Augenheilkd. 1977. PMID: 302878 German.
• [The cellular immunity indices of patients with malignant melanoma using the viral immunomodulator rigvir].

  Glinkina LS, Bruvere RZh, Venskus DR, Garklava RR, Muceniece AJ. Glinkina LS, et al. Vopr Onkol. 1992;38(5):540-7. Vopr Onkol. 1992. PMID: 1300752 Russian.
• ["Transfer factor". Experimental findings and prospects for its clinical use].

  Medunitsyn NV. Medunitsyn NV. Patol Fiziol Eksp Ter. 1977 Jan-Feb;(1):75-80. Patol Fiziol Eksp Ter. 1977. PMID: 325478 Review. Russian. No abstract available.
• Transfer factor and other T cell products.

  Tsang KY, Fudenberg HH. Tsang KY, et al. Springer Semin Immunopathol. 1986;9(1):19-32. doi: 10.1007/BF00201902. Springer Semin Immunopathol. 1986. PMID: 2425441 Review. No abstract available.